Valuation models
price $361.39 · as of Nov 2, 2026
DCF · Perpetuity growth · 5yused205.29 – 344.17260.2539% overvaluedDCF · Perpetuity growth · 10y247.00 – 397.94306.9518% overvaluedDCF · EBITDA exit · 5y552.10 – 608.73579.6438% undervaluedDCF · EBITDA exit · 10y528.93 – 633.92578.8738% undervaluedP/E · peers329.20 – 379.25355.632% overvaluedP/E · own history205.29 – 450.56371.473% undervaluedPEG—386.717% undervaluedEV/EBITDA · peers231.37 – 306.15292.3124% overvaluedEV/Revenue · peers443.75 – 1,315.61859.6058% undervaluedEarnings power value95.15 – 174.17127.06184% overvaluedDividend discount58.39 – 136.5286.83316% overvaluedWall St. consensus target—391.508% belowCost of capital (WACC)—7.80%—
DCF · Perpetuity growth · 5y leads for a mature, steady company — positive operating income and three years of positive free cash flow. How the headline model is chosen.
Model value · DCF · Perpetuity growth · 5y
260.25
Labcorp closed at $361.39 — overvalued by 39% vs model.
205.29the model's range344.17
DCF · Perpetuity growth · 5y leads for a mature, steady company — positive operating income and three years of positive free cash flow. From a five-year discounted cash flow.
Other models
86.83 – 859.60
Wall St. target
391.50 8% below
Above model, 1y
53 of 105 days
How it is valued
Valued asMature & stable
Low/slowing growth (~7% recent)Moderate margins (6% net margin)Highly cyclical earnings
Model estimates for research reference only, not investment advice. Every model rests on assumptions that may not match what happens; how each model works is in the manual.